n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, August 30th, 2016

The QualityStocks
Daily Stock List

graphic
graphic

Music of Your Life, Inc. (MYLI)

Real Pennies, PennyStocks24, Wallstreetbuzz, OtcShortReport, SmallCapVoice, OTPicks, AllPennyStocks, and Greenbackers reported previously on Music of Your Life, Inc. (MYLI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Music of Your Life, Inc. is a multi-media entertainment company based in Las Vegas, Nevada. The Company is the longest running syndicated music radio brand in broadcasting history featuring the "Adult Standards" genre. Music of Your Life produces live radio programming syndicated to varied AM, FM, and HD terrestrial radio stations. The Company lists on the OTC Markets Group’s OTCQB.

Music of Your Life produces live concerts, television shows, and radio programming in the United States. Its network streams across the Internet under the iRadio trademark. The Company has been on the air since 1978 and it presently produces live radio programming 24 hours a day. Its primary source of revenue comes from selling radio spots, or commercials on the network, and licensing its trade names.

The Company is also in the cruise business. Music of Your Life Cruises began more than 15 years ago, presenting musical acts on voyages around the world. Moreover, the Company is expanding its channel lineup to include Rock, Country, Jazz, and also other genres by way of its iRadio streaming Internet service.

Music of Your Life is expanding the network into new genres of music, each with its own celebrity host. Branded channels of the network will include the Malt Shop, Pop Rocks, Sammy's Smokin' Lounge, Rock-It, Cowboy Radio, Americana, Thelonious Funk, Surf Rat USA, Anthony's Garage, Martini Time, Juke Box Saturday Night, Topless Tuesday, Southern Fried Rock, and more. Music offerings will be from rock to country, pop to jazz, and a few sports and commentary offerings.

Music of Your Life Chief Executive Officer, Mr. Marc Angell, said, "Having your own radio show has become very popular these days, and there's many celebrities in music, television, and movies looking to do so. The concept makes sense for all involved, the talent gains exposure to their fans in a loose, non-scripted environment, and we gain access to their social media followers."

Music of Your Life, Inc. (MYLI), closed Tuesday's trading session at $0.001, even for the day, on 19,808,806 volume with 45 trades. The average volume for the last 60 days is 8,365,347 and the stock's 52-week low/high is $0.001/$0.10.

Oakridge Global Energy Solutions, Inc. (OGES)

Tip.us, SmallCapNetwork, MissionIR, Serious Traders, and StocksToBuyNow reported on Oakridge Global Energy Solutions, Inc. (OGES), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Palm Bay, Florida-based Oakridge Global Energy Solutions, Inc. is an integrated energy storage solutions enterprise. The Company utilizes state-of-the-art technology in the design, development, and manufacture of high-quality cells, batteries, and energy storage systems.  It is a leader in the innovation, development, manufacturing and marketing of disruptive energy storage technology for military, civilian and medical uses. Oakridge Global Energy Solutions lists on the OTC Bulletin Board.

The Company’s pioneering energy storage solutions form the foundation of the most contemporary green energy storage products. This permits its customers to establish themselves as trendsetters in their chosen marketplaces.

Oakridge supplies a comprehensive range of energy storage solutions. These include state-of-the-art battery management systems and batteries for golf cars, local electric vehicles, radio controlled vehicles, hand held devices, power tools, living space power, energy storage systems, starter motors, pressure tolerant, and underwater applications.

Oakridge’s research & development (R&D), and the Company’s strong strategic alliances with top Japanese industry players has led to the development of some of the globe’s most unique Lithium-ion "smart energy cells". These all have smart-phone connectivity to monitor status, and represent some of the longest-lasting rechargeable power sources now available, with a life up to three times greater and a 30 percent longer cycle between charges than Chinese-manufactured counterparts.

Oakridge Global Energy Solutions is in the process of building on its earlier announced Japanese strategic relationships. This is to integrate the latest in Lithium-ion technology from Japan into its second generation range of products that combine progressive technology with the inventive Oakridge "design DNA". The Company will continue to deepen its Japan presence and relationships during the balance 2016.

At the beginning of August, Oakridge Global Energy Solutions announced that after extensive design work internally during Q2 of 2016, it finished all design work on its new "Generation 2" series of lithium-ion smart energy cell products. The Company is currently readying these for commercial production during Q4 2016.

The new "Generation 2" product series includes an assortment of new lithium-ion smart energy cell products. These include the "ProSeries 2" Golf Car energy cells, the Freedom IV Lite and Ultra-Lite portable energy packs, the Freedom V Living Space Energy Storage unit, as well as the "UMed" portable universal medical device power pack for medical applications, including CPAP units.

Oakridge Global Energy Solutions, Inc. (OGES), closed Tuesday's trading session at $0.53, down 15.87%, on 149,429 volume with 69 trades. The average volume for the last 60 days is 99,271 and the stock's 52-week low/high is $0.23/$2.40.

Vitality Biopharma, Inc. (VBIO)

SmallCap Network reported on Vitality Biopharma, Inc. (VBIO), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.

Vitality Biopharma, Inc.’s commitment is to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. Since 2012, it has developed a unique capability for production of molecules via glycosylation, a form of enzymatic biosynthesis that was originally developed to improve the taste of stevia, a high-potency sweetener.

The platform is well suited for the discovery of new pharmaceutical products. Late last year, Vitality Biopharma successfully modified cannabidiol (CBD), which is not psychoactive, and in continuing work has created a novel class of pharmaceuticals known as cannabosides. Vitality Biopharma has its headquarters in Los Angeles, California.

Cannabosides, upon ingestion can enable the selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract. Site-specific delivery could enable oral drug formulations of cannabinoids to provide therapeutic benefits. This is while lessening or avoiding the systemic delivery of THC into the bloodstream.

Vitality Biopharma can biosynthesize cannabinoid glycosides (cannabosides) by way of enzyme biosynthesis. The Company is one of only a very few groups globally who
know how to produce and work with the enzymes that perform glycosylation. It has been focused on it because the same enzymes are used to modify the taste of the above-mentioned stevia (steviol glycosides). The Company was previously focused on stevia for four years. It created numerous different glycosylated versions of it, that is, next generation stevia sweeteners with better taste.

Last week, Vitality Biopharma announced a major expansion of its glycoside prodrug intellectual property (IP) portfolio via the filing of U.S. patent application 62/363,808. This expands upon two previous patent applications filed in late 2015. The Company’s IP portfolio now includes novel pharmaceutical prodrugs of all major phytocannabinoids that are derived from the Cannabis sativa plant, and all major endocannabinoids that are the cannabinoid signaling molecules produced within the body.

Furthermore, the new patent filing includes glycoside prodrugs of an array of additional compounds, including synaptamide, which promotes neural repair, and also vanilloids, which are known to provide pain relief through targeting of the TRPV1 receptor.

Mr. Robert Brooke, Vitality Biopharma’s CEO, said, "Our glycosylation platform has now yielded a diverse array of pharmaceutical prodrugs, including cannabosides and other compounds that can exert potent anti-inflammatory effects and pain relief. The benefit is clear for inflammatory bowel disease, and we look forward to examining their potential in other disease indications as well."

Vitality Biopharma, Inc. (VBIO), closed Tuesday's trading session at $0.755, up 13.53%, on 361,905 volume with 111 trades. The average volume for the last 60 days is 16,811 and the stock's 52-week low/high is $0.30/$2.25.

PharmaCyte Biotech, Inc. (PMCB)

Damn Good Penny Picks, Penny Picks, InvestorPlace, Wall Street Corner, Stock Market Media Group, Goldman Small Cap Research, SmallCapNetwork, and OTCJournal reported on PharmaCyte Biotech, Inc. (PMCB), and we also report on the Company, here at the QualityStocks Daily Newsletter.

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company that centers on developing targeted treatments for cancer and diabetes applying its signature live cell encapsulation technology, Cell-in-a-Box®. This unique and patented technology is being used as a platform upon which treatments for many kinds of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. PharmaCyte Biotech is based in Silver Spring, Maryland.

Additionally, PharmaCyte is working towards improving the quality of life of patients with advanced pancreatic cancer and on developing treatments for other types of solid cancerous tumors. Its treatment for pancreatic cancer involves low doses of the recognized anticancer prodrug ifosfamide, together with encapsulated live cells that convert ifosfamide into its active or "cancer-killing" form. These capsules are placed as close to the cancerous tumor as possible. This is to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer.

PharmaCyte is also developing treatments for cancer founded upon chemical constituents of the Cannabis plant, called cannabinoids. The Company is examining ways to exploit the benefits of Cell-in-a-Box® technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects normally associated with cancer treatments.

The live-cell encapsulation technology that it utilizes is a way to enclose living cells in protective “cocoons” around the size of the head of a pin. PharmaCyte encapsulates living cells, not drugs.  Each capsule can enclose about 10,000 cells. This number can vary depending upon the size of the cells encapsulated.

PharmaCyte Biotech is advancing its new treatment for pancreatic cancer into the clinic in the United States, with study sites in Europe and Australia.  Its clinical trial in pancreatic cancer will get underway with Translational Drug Development (TD2) coordinating the trial globally and conducting it in the U.S.  Clinical Network Services (CNS) will conduct the trial in Europe and Australia in alliance with TD2.

PharmaCyte Biotech has 20 years of patent protection in the United States for the "Melligen" cells. These are a part of its therapy for Type 1 and insulin-dependent Type 2 diabetes. PharmaCyte is developing a treatment for Type 1 diabetes and insulin-dependent Type 2 diabetes. Its plan is to encapsulate a human cell line, which has been genetically engineered to produce, store, and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done employing the Cell-in-a-Box® technology.

In early August, PharmaCyte Biotech announced that on Saturday, July 30, 2016, the Company’s Medical and Scientific Advisory Board member Mark L. Rabe, MD, delivered a presentation entitled “Medical Cannabis for Cancer” as part of a “Cannabis for Cancer Forum” in San Diego, California. Dr. Rabe provided educational information to individuals interested in learning more about cannabinoid-based therapies in treating cancer. He explained PharmaCyte Biotech’s continuing research at the University of Northern Colorado (UNC) to exploit the benefits of the Cell-in-Box® technology to develop therapies for cancer, based upon the constituents of the Cannabis plant (cannabinoids).

PharmaCyte Biotech, Inc. (PMCB), closed Tuesday's trading session at $0.0379, down 0.26%, on 1,374,802 volume with 109 trades. The average volume for the last 60 days is 1,891,701 and the stock's 52-week low/high is $0.0295/$0.13.

Elite Pharmaceuticals, Inc. (ELTP)

Marketbeat.com, Pennybuster, PennyStocks24, TopPennyStockMovers, SmallCapVoice, and Top Stock Picks reported on Elite Pharmaceuticals, Inc. (ELTP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTC BB-listed, Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. A specialty pharmaceutical company, it is developing a pipeline of proprietary pharmacological abuse-deterrent opioid products and also niche generic products.  Elite specializes in oral sustained and controlled release drug products, which have high barriers to entry. Elite Pharmaceuticals is based in Northvale, New Jersey, where it operates a GMP and DEA registered facility for research, development, and manufacturing.

In addition, Elite provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.). Elite owns generic and OTC products that have been licensed to TAGI Pharma, Epic Pharma and Valeant Pharmaceuticals International.

Currently, Elite Pharmaceuticals has eight commercial products selling, additional approved products pending manufacturing site transfer, and the NDA for SequestOx™, for which it just received the CRL from the FDA.  The Company’s lead pipeline products include abuse-deterrent opioids that utilize its patented proprietary technology and a once-daily opioid. These products include sustained release oral formulations of opioids for the treatment of chronic pain.

Regarding Elite’s proprietary abuse-deterrent technology, ART™, it is a multi-particulate capsule that contains an opioid agonist in addition to naltrexone, an opioid antagonist used chiefly in the management of alcohol dependence and opioid dependence. When the product is taken as intended, the design of naltrexone is to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed.

Earlier this month, Elite Pharmaceuticals announced that it filed an Abbreviated New Drug Application (ANDA) with the FDA for a generic version of Percocet (oxycodone hydrochloride and acetaminophen, USP CII) 5 mg, 7.5 mg, and 10 mg tablets with 325 mg of acetaminophen. Percocet is a combination medication. It is used to help relieve moderate to severe pain.

Yesterday, Elite Pharmaceuticals announced it entered into a Development and License Agreement with SunGen Pharma, LLC to collaborate to develop and commercialize four generic pharmaceutical products. With this agreement, Elite Pharmaceuticals and SunGen Pharma will share in the responsibilities and costs in the development of the products.

Upon approval, the products will be owned jointly by Elite Pharmaceuticals and SunGen Pharma. SunGen shall have the exclusive right to market and sell two of the products using SunGen’s label. Elite shall have the exclusive right to market and sell two of the products using Elite’s label.  Elite Pharmaceuticals will manufacture and package all four products on a cost plus basis.

Elite Pharmaceuticals, Inc. (ELTP), closed Tuesday's trading session at $0.21354, up 11.28%, on 31,710,298 volume with 174 trades. The average volume for the last 60 days is 13,082,985 and the stock's 52-week low/high is $0.0015/$0.143.

graphic

The QualityStocks
Company Corner

graphic
graphic

Star Mountain Resources, Inc. (SMRS)

The QualityStocks Daily Newsletter would like to spotlight Star Mountain Resources, Inc. (SMRS). Today, Star Mountain Resources, Inc. closed trading at $0.25, even for the day. The stock’s average daily volume over the past 60 days is 4,180, and its 52-week low/high is $0.25/$1.14.

Star Mountain Resources, Inc. was pleased to announce today the results of its district-wide review and evaluation of the historic exploration drilling program that targeted zinc mineralization in the Balmat-Edwards Mining District, St. Lawrence County, New York. Our review identified significant potential zinc mineralization in the Upper Marble unit (the host unit for zinc mineralization for all the mines in the Balmat-Edwards District) at a location approximately one mile southwest of the historic Hyatt Mine and four miles northeast of the Balmat #4 Mine (the "Sully discovery").

Star Mountain Resources, Inc. (SMRS), a minerals exploration company, is focused on acquiring and consolidating mining claims, mineral leases, producing mines, and historic mines with production and future growth potential identified through exploration efforts. The company's operations are currently focused on the initiation, production and expansion of acquired mineral resources in the Star Mountain Mining District, Beaver County, Utah and turning them into producing assets.

Comprised of 2,320 acres, the company's Star Mountain/Chopar Mine project consists of 116 lode-mining claims and four metalliferous mineral lease sections located in the Star Mountain range, Star Mining District, in Beaver County, Utah, approximately five miles west of Milford, Utah. Exploration activities to date include geological analysis, and a limited reverse circulation & core drilling program.

The Star Mountain Mining District, which is dotted with historic mines dating back to the late 1800s, has a long and storied history within the mining industry. The company believes that the application of modern exploration tools will reveal additional resources that were previously unattainable. Leveraging the region's mild climate and accessibility to nearby rail lines and roads, management will look to translate this potential into sustainable returns in the years to come.

Star Mountain Resources has adopted a discovery-based business model to grow its industry presence in the future. The company plans to thoroughly explore and initially develop its leasehold before seeking senior industry partners to assist in the capital-intensive development and operation phases. Building on this strategy, Star Mountain Resources will also continue to seek quality projects that can be evaluated on their own technical and financial merit. Disclaimer

Star Mountain Resources, Inc. Company Blog

Star Mountain Resources, Inc. News:

Star Mountain Resources Reports on Sully Discovery Following Evaluation of Exploration Targets in the Balmat-Edwards Mining District, St. Lawrence County, New York

Star Mountain Resources Subsidiary Secures $500,000 Loan From a New York Public Benefit Trust

Star Mountain Resources Receives Industry Guide 7 Mineral Reserves Report on Balmat Mine

WRIT Media Group, Inc. (WRIT)

The QualityStocks Daily Newsletter would like to spotlight WRIT Media Group, Inc. (WRIT). Today, WRIT Media Group, Inc. closed trading at $0.17, up 3.03%, on 2,666 volume with 7 trades. The stock’s average daily volume over the past 60 days is 114,527, and its 52-week low/high is $0.13/$1.50.

WRIT Media Group, Inc. (WRIT) is a diversified media and software company focused on expanding in the digital media industry. The company specializes in production and distribution; video game distribution via mobile platforms; and digital currency software development, including trading platforms and Blockchain solutions. WRIT's current portfolio includes Front Row Networks, Retro Infinity, Amiga Games and Pandora Venture Capital.

Front Row Networks is a content creation company that produces, acquires and distributes live event programming for initial worldwide digital broadcast into digitally enabled movie theaters and online streaming.

Software company Amiga Games is resurrecting the Amiga brand by publishing popular retro video games of the past for use on today's smartphones, modern game consoles, micro-consoles, PCs, and tablets.

Retro Infinity, Inc. serves as a video game distribution portal which publishes video games from Amiga, Atari, and other retro brands. The company leverages these platform and classic game brands, coupled with proprietary technologies, to create new revenue from dormant game libraries.

Pandora Venture Capital is a software developer with a focus on digital currency technologies, including a cryptocurrency trading platform, a new generation of cryptocurrency, and Blockchain technology solutions. Blockchain technology is emerging as a useful technology solution in payment processing, loyalty rewards, healthcare record management, insurance, and legal contracts management.

Together with its subsidiaries, WRIT Media Group is focused on benefitting from the widespread market growth and increased demand for alternative theatrical, mobile and interactive content, as well as digital currency. Disclaimer

WRIT Media Group, Inc. Company Blog

WRIT Media Group, Inc. News:

WRIT Media Group Announces New Funding Round

WRIT Media Group Announces Development of Blockchain-Based Payment Systems

WRIT Media Group Details Pandora Venture Capital Corp. Acquisition

Giggles N' Hugs, Inc. (GIGL)

The QualityStocks Daily Newsletter would like to spotlight Giggles N' Hugs, Inc. (GIGL). Today, Giggles N' Hugs, Inc. closed trading at $0.02, even for the day, on 20,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 84,612, and its 52-week low/high is $0.0137/$0.23.

Los Angeles-based Giggles N' Hugs, Inc. (GIGL) is a first-of-its-kind, award-winning family restaurant and play space that combines organic gourmet food with the play elements for children in a 2500-square-foot play space in the middle of the restaurant. The concept is similar to Chuck E. Cheese, but offers a unique healthier, high-end version for health conscious parents and families. Parents eat and relax while the kids have an incredible time playing in the custom-made play area with giant climbers, dragons, castles, pirate ships slides and swings and a multitude of other toys.

In addition to nightly shows and concerts, every 30 minutes Giggles N' Hugs provides an activity such as face painting, disco dance parties, karaoke, games, arts and crafts, and much more. Giggles N' Hugs has been voted the No. 1 family restaurant, No. 1 birthday party place, and the No. 1 indoor play space in all of Los Angeles, and has attracted a star-studded list of customers including Sandra Bullock, Heidi Klum, Jessica Alba, Halle Berry, Jennifer Garner and Ben Affleck, Denis Quaid, Mark Whalberg, Adam Sandler, Dustin Hoffman and many more.

Revenue is derived from several sources, including food and beverage sales, beer and wine, birthday parties (40%), admission and membership fees to play, along with retail sales. These revenue-generating locations are also highly sought-after tenants. The company currently has three locations in the top premier malls around Los Angeles; four of the largest mall owners in the country are giving Giggles N' Hugs up to 75% discounts on rent and providing upward of $700,000 of upfront cash for each location to get Giggles N' Hugs into their malls around the country.

Growth and recognition of this caliber are driven by a very powerful management team. Giggles N' Hugs President John Kaufman was the COO at California Pizza Kitchen when the founders had just two locations. Joined by Giggles N' Hugs' CFO Phillip Gay, who at the time was CFO of California Kitchen, Kaufman grew the company from two to more than 100 locations – at which time it was bought by Pepsi Co. Kaufman was recruited as president of Koo Koo Roo Chicken, one of the fastest growing fast-casual concepts on the west coast, while Gay joined Wolfgang Puck Restaurants group as CFO, eventually becoming the CEO.

Giggles N' Hugs was founded as a truly "kid friendly" establishment catered specifically to the size, interests, and nutrition needs of children. Since opening its first Giggles N' Hugs in 2009, the company has received a steady stream of interest from more than 300 interested parties looking to expand the concept – via franchise or master licenses – in the U.S. as well globally in countries such as Germany, England, Dubai, Russia, Colombia, Australia , Singapore, Turkey, among the many more. Disclaimer

Giggles N' Hugs, Inc. Company Blog

Giggles N' Hugs, Inc. News:

Giggles N’ Hugs, Inc. (GIGL) engages Kiddos, Inc. and Michelle Steinberg of dOMAIN Integrated to Launch New Marketing and PR Initiatives

Repeat: Giggles N Hugs to present at the 9th annual LD Micro Conference main event

Giggles N' Hugs, Inc. (GIGL) CEO Discusses 2016 Growth Strategies in Second QualityStocks Interview

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0085, off by 1.16%, on 340,400 volume with 8 trades. The stock’s average daily volume over the past 60 days is 924,453, and its 52-week low/high is $0.0041/$0.018.

Singlepoint, Inc. (SING) provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. Through diversification of its own model, the company is also leveraging its core technology to expand into the mobile auctions and daily fantasy sports markets.

SING currently has two fundraising solutions. Text2Bid is an interactive way to increase auction revenues. The technology makes it easy for people to bid in auctions from any text or web-enabled phone. Donate by Text allows nonprofits to securely collect one-time or recurring donations via text. This capability creates a personal experience for the donors, and enables ongoing communication between the donor and nonprofit or event sponsor.

SING's payment solutions include point-of-sale (POS) terminals, loyalty programs, payment processing, phone services and financing. Pay by Text™ enables a business to accept payment transactions and, in essence, turns the user's mobile phone into a point-of-sale device. Operating on the same platform as mobile marketing, Pay by Text is designed to increase revenues, raise the average per-transaction amount, and create a fast, easy and hassle-free method of payment.

As part of its diversification and expansion strategy, SING recently acquired an interest in DraftFury (www.draftfury.com), a company that offers skill-based NBA, NFL and MLB daily fantasy sports (DFS) contests. DraftFury is known for its innovative offerings and originality, and is the first cash-flow-positive DFS enterprise. This transaction places SING in a multi-billion dollar industry expected to generate entry fees of $14.4 billion in 2020. Under the guidance of a leadership team well-versed in technology, engineering, marketing and raising capital, SING anticipates a strong foothold in its chosen markets. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

SinglePoint, Inc. to Capitalize on the Multi-Million Dollar 'Pokemon Go' Phenomenon With Custom Mobile Application

SinglePoint, Inc. Identifies Acquisition and Funding Targets; Updates on MaloneBailey Audit Toward Uplist

A New Audio Interview with Greg Lambrecht, CEO of SinglePoint Inc., is Now at SmallCapVoice.com

Agora Holdings, Inc. (AGHI)

The QualityStocks Daily Newsletter would like to spotlight Agora Holdings, Inc. (AGHI). Today, Agora Holdings, Inc. closed trading at $0.1176, off by 5.84%, on 46,332 volume with 12 trades. The stock’s average daily volume over the past 60 days is 23,795, and its 52-week low/high is $0.03/$0.7999.

Agora Holdings, Inc. (AGHI), together with its wholly-owned subsidiary, Geegle Media, is leading a diversified family entertainment and media enterprise through business segments which include: TV on Demand, interactive media, business products and consumer platforms. With its multi-dimensional approach, Geegle Media supports Agora Holdings' mission to deliver innovate and high-quality business solution products and to deliver video content from around the world.

Geegle Media web platforms include; GeegleTV, Frame, 1000Salads, RealtyTV and LobbyTV. Geegle TV is a multi-platform video entertainment website that curates high-quality video content from around the world. In 2016, GeegleTV will serve as co-producer by airing original content. By exposing undiscovered content to millions of users and rendering it shareable to social media, Geegle TV will serve as a marketing partner to local and internationally based TV shows not yet on the open market.

For commercial use, Geegle Media provides a variety of solutions that include web development and billing software for VoIP applications. RealtyTV is its state-of-the-art platform for real estate brokerages. LobbyTV is another of its widely used products by business offices. For individuals, Geegle TV combines radio, On Demand movies, news, sports and children's content.

Geegle Media is also developing 1000salads, an online hub that encourages healthy lifestyles. The portal will feature recipes and products, health-oriented articles and a curated selection of local restaurants and grocers that deliver to the health-conscious user. Currently in its alpha stage of development, 1000salads is gearing up its sales and marketing in preparation for its launch in 2016.

Geegle Media differs from other On Demand providers, such as Netflix and HBO, in that its service is free of constraints such as subscription, fees and penalties. As consumers increasingly opt for personalized sources of entertainment, Agora recognizes the vast opportunities and growth potential provided by the rising popularity of TV On Demand. The company also benefits from strong and visionary management with a track record of bringing innovative ideas to fruition. Disclaimer

Agora Holdings, Inc. Company Blog

Agora Holdings, Inc. News:

Agora Holdings Inc. Audit Is Complete, Company Continuing to Progress Its Plans to Move Up the Board to QB Level

Agora Holdings, Inc. Updates Shareholders on FRAME Technology, Accounting Audit

Agora Holdings Inc. Signs Engagement Letter With Auditing Firm, BF Borgers CPA PC

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Profitable Trader Authority
(MVES)

2.

WealthMakers
(RIGL)

3.

Daily Trade Alert
(KPTI)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251